Literature DB >> 21854504

Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.

Xiao-Yu Jia1, Zhen Qu, Zhao Cui, Rui Yang, Juan Zhao, Ming-Hui Zhao.   

Abstract

AIM: Cases with anti-glomerular basement membrane (GBM) disease have been reported with linear deposit of immunoglobulin G (IgG) along GBM, but have undetectable anti-GBM antibodies in circulation by enzyme linked immunosorbent assays (ELISA). We speculated that the structure of the antigens recognized by these antibodies may contribute to the negative results of ELISA.
METHODS: Sera from four patients were collected, with typical linear deposit of IgG along GBM but no anti-GBM reactivity by commercial ELISA kits. Circulating anti-GBM antibodies were detected by indirect immunofluorescence. Antigen specificity and its conformational structure was investigated by western-blot analysis, using recombinant human α1-α5(IV)NC1 and chimeric proteins E(A) and E(B) as antigens.
RESULTS: The presence of circulating anti-GBM antibodies were confirmed by indirect immunofluorescence with linear deposit of IgG towards cryptic epitopes along GBM on normal kidney sections. These antibodies did not recognize recombinant human α1, α2, α4 or α5(IV)NC1, but could blot α3(IV)NC1 under non-reducing non-boiling conditions on western-blot analysis, when the conformational epitope(s) on α3(IV)NC1 were thought to be preserved. When α3(IV)NC1 was prepared under reducing conditions with β-mercaptoethanol and/or boiled to destroy the disulfide bonds, the binding with the antibodies disappeared. Moreover, these antibodies recognized neither E(A) nor E(B) , indicating their distinct epitope repertoire.
CONCLUSION: Circulating anti-GBM antibodies undetectable by ELISA could recognize cryptic and conformation-dependent epitopes restricted on α3(IV)NC1, distinct from E(A) and E(B) . Indirect immunofluorescence was necessary for antibody detection and treatment monitoring under such circumstances.
© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21854504     DOI: 10.1111/j.1440-1797.2011.01511.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  11 in total

1.  Serodiagnosis of Anti-glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay.

Authors:  Alexander Kühnl; Lea Hartwig; Cornelia Dähnrich; Wolfgang Schlumberger
Journal:  Front Med (Lausanne)       Date:  2022-07-04

2.  A case of triple pathology: seronegative anti-glomerular basement membrane antibody-mediated glomerulonephritis and membranous nephropathy in a patient with underlying diabetic kidney disease.

Authors:  Sven-Jean Tan; Kathryn Ducharlet; Karen M Dwyer; Damian Myers; Robyn G Langham; Prue A Hill
Journal:  Clin Kidney J       Date:  2013-06

3.  Necrotizing RPGN with linear anti IgG deposits in a patient with history of granulomatosis with polyangiitis: a case report.

Authors:  Ninad Parekh; Edward Epstein; Suzanne El-Sayegh
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-11-27

4.  Nodular glomerulosclerosis with anti-glomerular basement membrane-like glomerulonephritis; a distinct pattern of kidney injury observed in smokers.

Authors:  Ibrahim Batal; Daisy B Reyes; Sandy Popham; Vanesa Bijol
Journal:  Clin Kidney J       Date:  2014-06-26

5.  Factors Associated With Pathogenicity of Anti-Glomerular Basal Membrane Antibodies: A Case Report.

Authors:  Rime Ossman; David Buob; Thomas Hellmark; Isabelle Brocheriou; Julie Peltier; Ryad Tamouza; Karine Dahan; Alexandre Hertig; Eric Rondeau; Pierre Galichon
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

6.  Atypical anti-glomerular basement membrane disease.

Authors:  Megan L Troxell; Donald C Houghton
Journal:  Clin Kidney J       Date:  2015-12-30

7.  Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.

Authors:  Ibrahim Ismail; Sonu Nigam; Alan Parnham; Vinay Srinivasa
Journal:  J Med Case Rep       Date:  2017-08-06

8.  An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.

Authors:  Astrid Behnert; Marvin J Fritzler; Beina Teng; Meifeng Zhang; Frank Bollig; Hermann Haller; Andrej Skoberne; Michael Mahler; Mario Schiffer
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

9.  Atypical anti-glomerular basement membrane disease: lessons learned.

Authors:  Richard J Glassock
Journal:  Clin Kidney J       Date:  2016-07-28

10.  Frequently relapsing anti-glomerular basement membrane antibody disease with changing clinical phenotype and antibody characteristics over time.

Authors:  Bobby Gu; Alex B Magil; Sean J Barbour
Journal:  Clin Kidney J       Date:  2016-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.